Healthy volunteers help shape future Alzheimer's drug
NCT ID NCT07334860
First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This early-stage study is testing two different versions of MK-1167, an experimental medicine being developed for Alzheimer's disease, in 16 healthy adults. The main goal is to see how the drug moves through the body and to check its safety before testing it in people with Alzheimer's. Participants must be in good health and not smoke.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
QPS-MRA, LLC ( Site 0001)
South Miami, Florida, 33143, United States
Conditions
Explore the condition pages connected to this study.